Skip to main content
Erschienen in: Journal of Hepato-Biliary-Pancreatic Sciences 6/2013

01.08.2013 | Original article

New-onset diabetes mellitus developing in Asian adult living donor liver transplant recipients: a single-center experience

verfasst von: Nobuhiro Harada, Yasuhiko Sugawara, Nobuhisa Akamatsu, Junichi Kaneko, Sumihito Tamura, Taku Aoki, Yoshihiro Sakamoto, Kiyoshi Hasegawa, Noriyo Yamashiki, Norihiro Kokudo

Erschienen in: Journal of Hepato-Biliary-Pancreatic Sciences | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

New-onset diabetes mellitus (NODM) after liver transplantation is a common complication with a potentially negative impact on patient outcome.

Methods

To evaluate the incidence of NODM and its impact on Asian adult living donor liver transplant (LDLT) recipients, we investigated 369 adult LDLT cases in our institute.

Results

Preoperative diabetes mellitus (DM) was diagnosed in 38 (9 %) patients. NODM was observed in 128/331 (38 %) patients, 56 (44 %) with persistent NODM and 72 (56 %) with transient NODM. The mean interval between LDLT and the development of NODM was 0.6 ± 1.8 (range 0–1.4) months. Multivariate analyssis revealed that older age, being male and having a higher body mass index were independent risk factors among recipients for developing NODM, while hepatitis C virus infection was not a significant risk factor, and DM had no impact on patient outcome.

Conclusions

Although the long-term effect of DM on outcome remains to be investigated, the presence of DM after liver transplant, whether it was NODM or preexisting DM, had no impact on LDLT recipients’ outcomes in mid-term.
Literatur
1.
Zurück zum Zitat John P, Thuluvath P. Outcome of liver transplantation in patients with diabetes mellitus: a case-control study. Hepatology. 2001;34:889–95.PubMedCrossRef John P, Thuluvath P. Outcome of liver transplantation in patients with diabetes mellitus: a case-control study. Hepatology. 2001;34:889–95.PubMedCrossRef
2.
Zurück zum Zitat Kuo HT, Sampaio MS. Risk factors for new-onset diabetes mellitus in adult transplantation recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database. Transplantation. 2010;15:1134–40.CrossRef Kuo HT, Sampaio MS. Risk factors for new-onset diabetes mellitus in adult transplantation recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database. Transplantation. 2010;15:1134–40.CrossRef
3.
Zurück zum Zitat Chen T, Jia H, Li J, Chen X, Zhou H, Tian H. New onset diabetes mellitus after liver transplantation and hepatitis C virus infection: meta-analysis of clinical studies. Transpl Int. 2009;22:408–15.PubMedCrossRef Chen T, Jia H, Li J, Chen X, Zhou H, Tian H. New onset diabetes mellitus after liver transplantation and hepatitis C virus infection: meta-analysis of clinical studies. Transpl Int. 2009;22:408–15.PubMedCrossRef
4.
Zurück zum Zitat Saliba F, Lakehal M, Pageaux GP, Roche B, Vanlemmens C, Duvoux C, et al. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection: an observational multicenter study. Liver Transplant. 2007;13:136–44.CrossRef Saliba F, Lakehal M, Pageaux GP, Roche B, Vanlemmens C, Duvoux C, et al. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection: an observational multicenter study. Liver Transplant. 2007;13:136–44.CrossRef
5.
Zurück zum Zitat Gaynor JJ, Moon JI, Kato T, Nishida S, Selvaggi G, Levi DM, et al. A cause-specific hazard rate analysis of prognostic factors among 877 adults who received primary orthotopic liver transplantation. Transplantation. 2007;84:155–65.PubMedCrossRef Gaynor JJ, Moon JI, Kato T, Nishida S, Selvaggi G, Levi DM, et al. A cause-specific hazard rate analysis of prognostic factors among 877 adults who received primary orthotopic liver transplantation. Transplantation. 2007;84:155–65.PubMedCrossRef
6.
Zurück zum Zitat Moon JI, Barbeito R, Faradji RN, Gaynor JJ, Tzakis AG. Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: long-term follow up. Transplantation. 2006;82:1625–8.PubMedCrossRef Moon JI, Barbeito R, Faradji RN, Gaynor JJ, Tzakis AG. Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: long-term follow up. Transplantation. 2006;82:1625–8.PubMedCrossRef
7.
Zurück zum Zitat Kishi Y, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Makuuchi M. New-onset diabetes mellitus after living donor liver transplantation: possible association with hepatitis C. Transplant Proc. 2006;38:2989–92.PubMedCrossRef Kishi Y, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Makuuchi M. New-onset diabetes mellitus after living donor liver transplantation: possible association with hepatitis C. Transplant Proc. 2006;38:2989–92.PubMedCrossRef
8.
Zurück zum Zitat Driscoll CJ, Cashion AK, Hathaway DK, Thompson C, Conley Y, Gaber O, et al. Posttransplant diabetes mellitus in liver transplant recipients. Prog Transplant. 2006;16:110–6.PubMed Driscoll CJ, Cashion AK, Hathaway DK, Thompson C, Conley Y, Gaber O, et al. Posttransplant diabetes mellitus in liver transplant recipients. Prog Transplant. 2006;16:110–6.PubMed
9.
Zurück zum Zitat Mirabella S, Brunati A, Ricchiuti A, Pierini A, Franchello A, Salizzoni M. New-onset diabetes after liver transplantation. Transplant Proc. 2005;37:2636–7.PubMedCrossRef Mirabella S, Brunati A, Ricchiuti A, Pierini A, Franchello A, Salizzoni M. New-onset diabetes after liver transplantation. Transplant Proc. 2005;37:2636–7.PubMedCrossRef
10.
Zurück zum Zitat Pageaux GP, Faure S, Bouyabrine H, Bismuth M, Assenat E. Long-term outcomes of liver transplantation: diabetes mellitus. Liver Transplant. 2009;15:79–82.CrossRef Pageaux GP, Faure S, Bouyabrine H, Bismuth M, Assenat E. Long-term outcomes of liver transplantation: diabetes mellitus. Liver Transplant. 2009;15:79–82.CrossRef
11.
Zurück zum Zitat Oufroukhi L, Kamar N, Muscari F, Lavayssière L, Guitard J, Ribes D, et al. Predictive factors for posttransplant diabetes mellitus within one-year of liver transplantation. Transplantation. 2008;85:1436–42.PubMedCrossRef Oufroukhi L, Kamar N, Muscari F, Lavayssière L, Guitard J, Ribes D, et al. Predictive factors for posttransplant diabetes mellitus within one-year of liver transplantation. Transplantation. 2008;85:1436–42.PubMedCrossRef
12.
Zurück zum Zitat Sugawara Y, Makuuchi M, Kaneko J, Ohkubo T, Matsui Y, Imamura H, et al. Living-donor liver transplantation in adults: Tokyo University experience. J Hepatobiliary Pancreat Surg. 2003;10:1–4.PubMed Sugawara Y, Makuuchi M, Kaneko J, Ohkubo T, Matsui Y, Imamura H, et al. Living-donor liver transplantation in adults: Tokyo University experience. J Hepatobiliary Pancreat Surg. 2003;10:1–4.PubMed
13.
Zurück zum Zitat Kokudo N, Sugawara Y, Imamura H, Sano K, Makuuchi M. Tailoring the type of donor hepatectomy for adult living donor liver transplantation. Am J Transplant. 2005;5:1694–703.PubMedCrossRef Kokudo N, Sugawara Y, Imamura H, Sano K, Makuuchi M. Tailoring the type of donor hepatectomy for adult living donor liver transplantation. Am J Transplant. 2005;5:1694–703.PubMedCrossRef
14.
Zurück zum Zitat Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Omata M, et al. Selection of liver-transplant candidates for adult-to-adult living donor liver transplantation as the only surgical option for end-stage liver disease. Liver Transplant. 2006;12:1077–83.CrossRef Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Omata M, et al. Selection of liver-transplant candidates for adult-to-adult living donor liver transplantation as the only surgical option for end-stage liver disease. Liver Transplant. 2006;12:1077–83.CrossRef
15.
Zurück zum Zitat Sugawara Y, Makuuchi M, Kaneko J, Ohkubo T, Imamura H, Kawarasaki H. Correlation between optimal tacrolimus doses and the graft weight in living donor liver transplantation. Clin Transplant. 2002;16:102–6.PubMedCrossRef Sugawara Y, Makuuchi M, Kaneko J, Ohkubo T, Imamura H, Kawarasaki H. Correlation between optimal tacrolimus doses and the graft weight in living donor liver transplantation. Clin Transplant. 2002;16:102–6.PubMedCrossRef
16.
Zurück zum Zitat Tamura S, Sugawara Y, Kishi Y, Akamatsu N, Kaneko J, Murai N, et al. Conversion to cyclosporine provides valuable rescue therapy for living donor adult liver transplant patients intolerant to tacrolimus: a single-center experience at the University of Tokyo. Transplant Proc. 2004;36:3242–4.PubMedCrossRef Tamura S, Sugawara Y, Kishi Y, Akamatsu N, Kaneko J, Murai N, et al. Conversion to cyclosporine provides valuable rescue therapy for living donor adult liver transplant patients intolerant to tacrolimus: a single-center experience at the University of Tokyo. Transplant Proc. 2004;36:3242–4.PubMedCrossRef
17.
Zurück zum Zitat Sugawara Y, Tamura S, Yamashiki N, Kaneko J, Aoki T, Sakamoto Y, et al. Preemptive antiviral treatment for hepatitis C virus after living donor liver transplantation. Transplant Proc. 2012;44:791–3.PubMedCrossRef Sugawara Y, Tamura S, Yamashiki N, Kaneko J, Aoki T, Sakamoto Y, et al. Preemptive antiviral treatment for hepatitis C virus after living donor liver transplantation. Transplant Proc. 2012;44:791–3.PubMedCrossRef
18.
Zurück zum Zitat American Diabetes Association: Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(Suppl 1):S5–20. American Diabetes Association: Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(Suppl 1):S5–20.
19.
Zurück zum Zitat Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transplant. 2004;10:349–55.CrossRef Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transplant. 2004;10:349–55.CrossRef
20.
Zurück zum Zitat Leonard J, Heimbach JK, Malinchoc M, Watt K, Charlton M. The impact of obesity on long-term outcomes in liver transplant recipients—results of the NIDDK liver transplant database. Am J Transplant. 2008;8:667–72.PubMedCrossRef Leonard J, Heimbach JK, Malinchoc M, Watt K, Charlton M. The impact of obesity on long-term outcomes in liver transplant recipients—results of the NIDDK liver transplant database. Am J Transplant. 2008;8:667–72.PubMedCrossRef
21.
Zurück zum Zitat Lecube A, Hernández C, Genescà J, Simó R. Glucose abnormalities in patients with hepatitis C virus infection: epidemiology and pathogenesis. Diabetes Care. 2006;29:1140–9.PubMedCrossRef Lecube A, Hernández C, Genescà J, Simó R. Glucose abnormalities in patients with hepatitis C virus infection: epidemiology and pathogenesis. Diabetes Care. 2006;29:1140–9.PubMedCrossRef
22.
Zurück zum Zitat Delgado-Borrego A, Casson D, Schoenfeld D, Somsouk M, Terella A, Jordan SH, et al. Hepatitis C virus is independently associated with increased insulin resistance after live transplantation. Transplantation. 2004;77:703–10.PubMedCrossRef Delgado-Borrego A, Casson D, Schoenfeld D, Somsouk M, Terella A, Jordan SH, et al. Hepatitis C virus is independently associated with increased insulin resistance after live transplantation. Transplantation. 2004;77:703–10.PubMedCrossRef
23.
Zurück zum Zitat Gane EJ. Diabetes mellitus following liver transplantation in patients with hepatitis C virus: risks and consequences. Am J Transplant. 2012;12:531–8.PubMedCrossRef Gane EJ. Diabetes mellitus following liver transplantation in patients with hepatitis C virus: risks and consequences. Am J Transplant. 2012;12:531–8.PubMedCrossRef
24.
Zurück zum Zitat Trail KC, Stratta RJ, Larsen JL, Ruby EI, Patil KD, Langnas AN, et al. Results of liver transplantation in diabetic recipients. Surgery. 1993;114:650–6.PubMed Trail KC, Stratta RJ, Larsen JL, Ruby EI, Patil KD, Langnas AN, et al. Results of liver transplantation in diabetic recipients. Surgery. 1993;114:650–6.PubMed
25.
Zurück zum Zitat John PR, Thuluvath PJ. Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transplant. 2002;8:708–13.CrossRef John PR, Thuluvath PJ. Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transplant. 2002;8:708–13.CrossRef
26.
Zurück zum Zitat Foxton MR, Quaglia A, Muiesan P, Heneghan MA, Portmann B, Norris S, et al. The impact of diabetes mellitus on fibrosis progression in patients transplanted for hepatitis C. Am J Transplant. 2006;6:1922–9.PubMedCrossRef Foxton MR, Quaglia A, Muiesan P, Heneghan MA, Portmann B, Norris S, et al. The impact of diabetes mellitus on fibrosis progression in patients transplanted for hepatitis C. Am J Transplant. 2006;6:1922–9.PubMedCrossRef
27.
Zurück zum Zitat Krentz AJ, Wheeler DC. New-onset diabetes after transplantation: a threat to graft and patient survival. Lancet. 2005;365:640–2.PubMed Krentz AJ, Wheeler DC. New-onset diabetes after transplantation: a threat to graft and patient survival. Lancet. 2005;365:640–2.PubMed
Metadaten
Titel
New-onset diabetes mellitus developing in Asian adult living donor liver transplant recipients: a single-center experience
verfasst von
Nobuhiro Harada
Yasuhiko Sugawara
Nobuhisa Akamatsu
Junichi Kaneko
Sumihito Tamura
Taku Aoki
Yoshihiro Sakamoto
Kiyoshi Hasegawa
Noriyo Yamashiki
Norihiro Kokudo
Publikationsdatum
01.08.2013
Verlag
Springer Japan
Erschienen in
Journal of Hepato-Biliary-Pancreatic Sciences / Ausgabe 6/2013
Print ISSN: 1868-6974
Elektronische ISSN: 1868-6982
DOI
https://doi.org/10.1007/s00534-013-0602-6

Weitere Artikel der Ausgabe 6/2013

Journal of Hepato-Biliary-Pancreatic Sciences 6/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.